2025-11-12T11:07:25-08:00 2024-12-31 933524729 PENNOPTIC CPAs AND STRATEGIC PARTNERS LLC 117 N SIXTH STREET DENVER PA 17517 990 2024-01-01 800680447 CURE LGMD2i FOUNDATION CURE 7174057518 4028 MARIETTA AVENUE COLUMBIA PA 175128901 KELLY BRAZZO PRESIDENT/CEO 7174057518 2025-11-12 true true TIMOTHY K SWEIGART CPA P00966423 7173362891 2025-11-12 2024 2025-03-06 01:10:19Z KELLY BRAZZO 4028 MARIETTA AVENUE COLUMBIA PA 175128901 251444 false X www.curelgmd.com X 2011 PA FUND RESEARCH FOR CURE OF LIMB GIRDLE MUSCULAR DYSTROPHY 5 3 1 12 0 0 126556 184380 0 1989 14028 106711 24364 235256 222772 43524 263507 0 48825 0 0 62640 103213 106164 415545 129092 -192773 553188 360790 2614 2989 550574 357801 FUND RESEARCH FOR CURE OF LIMB GIRDLE MUSCULAR DYSTROPHY false false 393380 263507 0 THE ORGANIZATION ISSUED FIFTEEN ANNUAL RESEARCH GRANTS TO RESEARCH GROUPS/FACILITIES IN 2024. THE PURPOSE OF WHICH WAS TO FURTHER ADVANCE RESEARCHING THE TREATMENT OF LGMD. 393380 true true false false false false false false false false false false false false false false false false false false false true false false true false false true true false false false false false false false false false false false false false false false false false false true 0 0 1 true false false false false false false false false false false X 5 3 true false false false false false false true true false false false false false false false false false X KELLY BRAZZO 7174057518 4028 MARIETTA AVENUE COLUMBIA PA 175128901 X KELLY BRAZZO PRESIDENT/CEO 5.00 X 45000 0 0 DAN POPE VICE-PRESIDENT 5.00 X 0 0 0 KRISTEN OLSEN SECRETARY/TREASURER 1.00 X 0 0 0 JOHN SPENCER CREATIVE DIRECTOR/EXECUTIVE BOARD MEMBER 1.00 X 0 0 0 DR JEAN PIERRE LAURENT SCIENTIFIC DIRECTOR 1.00 X 0 0 0 KAITLYN NEROLADAKIS COMMUNICATIONS DIRECTOR/EXECUTIVE BOARD MEMBER 1.00 X 0 0 0 45000 false false false 184380 184380 14028 0 0 53036 28672 24364 0 24364 222772 14028 0 24364 156601 156601 106906 106906 45000 45000 0 0 3825 3825 0 0 250 0 250 0 2370 0 2370 0 5144 0 5144 0 27432 27432 0 0 72 0 72 0 3525 0 3525 0 BANK AND PROCESSING FEES 1754 0 1754 0 WEBSITE COSTS 7074 0 7074 0 STATE FILING FEES 1976 0 1976 0 AWARENESS PROGRAM COSTS 53616 53616 0 0 415545 393380 22165 0 113171 273510 440017 87280 553188 360790 2614 2989 2614 2989 X 544574 351801 6000 6000 550574 357801 553188 360790 -192773 X X true X false false false X 0 83704 114641 133513 126556 184390 642804 0 0 83704 114641 133513 126556 184390 642804 0 642804 578 45 93 1989 14028 16733 0 0 659537 0.97460 0.99520 X 0 0 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED Europe FUND RESEARCH 86906 WIRE TRANSFER 0 0 0 East Asia and Pacific FUND RESEARCH 20000 WIRE TRANSFER 0 0 0 2 true false false false false false Other PART IV LINE 1. THE FOUNDATION IS NOT REQUIRED TO FILE FORM 926 AS THE TRANSFER OF CASH TO THE FOREIGN ENTITY DID NOT RESULT IN OWNERSHIP OF 10% OR MORE OF THE VOTING POWER OF THE RECIPIENT ENTITY, NOR WAS THE AMOUNT TRANSFERRED MORE THAN $100,000 TO ANY SINGLE RECIPIENT CASINO NIGHT 53036 53036 17435 53036 53036 17435 17435 35601 true THE SPEAK FOUNDATION 71 EAST AVENUE NORWALK CT 06851 262087516 15000 2025 INTERNATIONAL LGMD CONFERENCE UNIVERSITY OF IOWA 285 NEWTON ROAD IOWA CITY IA 52242 426004813 10000 DYSTROGLYCANOPATHY PATIENT AND FAMILY CONFERENCE LGMD AWARENESS FOUNDATION 638 KENNEDY DR TWIN LAKES WI 53181 851504937 7000 10TH ANNUAL LGMD AWARENESS DAY SPONSORSHIP UMASS CHAN MEDICAL SCHOOL 55 LAKE AVENUE NORTH SUITE S1-859 WORCESTER MA 01655 043108190 23000 LGMD2I THERAPEUTICS FOR FKRP GENE CORRECTION VIA PRIME NATIONWIDE CHILDREN'S HOSPITAL 700 CHILDRENS DR COLUMBUS OH 43205 311036372 NOVEL GENE THERAPY 3 3 Pt VI, Line 11b PRESIDENT OF FOUNDATION REVIEWS FORM 990 BEFORE RETURN IS FILED. Pt VI, Line 2 PRESIDENT/CEO AND VICE PRESIDENT ARE HUSBAND AND WIFE. Pt VI, Line 15a THERE IS NO COMPENSATION PAID TO ANY OFFICER OF THE FOUNDATION. Pt VI, Line 15b THERE ARE NO COMPENSATED INDIVIDUALS OF THE FOUNDATION. ALL ASPECTS OF FOUNDATIONS ACTIVITIES ARE PERFORMED BY VOLUNTEERS. Pt VI, Line 19 DOCUMENTS REQUIRED TO BE DISCLOSED TO PUBLIC ARE MADE AVAILABLE UPON REQUEST. Pt XII, Line 2c PRESIDENT OF FOUNDATION SELECTED AND OVERSEES THE FINANCIAL STATEMENT PROCESS OF THE ACCOUNTANT.